Skip to content

Search for:

New to Type 1 Diabetes

Living with Diabetes

Conferences & Community

News

About CWD

New to Type 1 Diabetes
Living with Diabetes
Conferences & Community
CWD Answers
News
About CWD
Donate to CWD
Search for:

Archives

Research News

advertisement

September 12, 2012

On the Etiology of Type 1 Diabetes: A New Animal Model Signifying a Decisive Role for Bacteria Eliciting an Adverse Innate Immunity Response.
White Matter Structural Differences in Young Children With Type 1 Diabetes: A Diffusion Tensor Imaging Study.
Current evidence on the associations of breastfeeding, infant formula, and cow’s milk introduction with type 1 diabetes mellitus: a systematic review.
Dysregulated Toll-Like Receptor�Induced Interleukin-1beta and Interleukin-6 Responses in Subjects at Risk for the Development of Type 1 Diabetes.
The BH3-Only Proteins Bim and Puma Cooperate to Impose Deletional Tolerance of Organ-Specific Antigens. See also Immune cell death safeguards against autoimmune disease and Proteins offer protection from type 1 diabetes.

September 5, 2012

Maturation of Human Embryonic Stem Cell�Derived Pancreatic Progenitors Into Functional Islets Capable of Treating Pre-existing Diabetes in Mice. See also UBC scientists reverse diabetes in mice using stem-cell transplants.
Insulin resistance in multiple tissues in patients with type 1 diabetes mellitus on long term continuous subcutaneous insulin infusion therapy.
A strategy for combining minor genetic susceptibility genes to improve prediction of disease in type 1 diabetes.
Type I diabetes among children and young adults: the role of country of birth, socioeconomic position and sex.
Factors That Influence Parental Attitudes toward Enrollment in Type 1 Diabetes Trials. Free full text available in HTML and PDF formats.

August 30, 2012

Blood Glucose Control in Type 1 Diabetes With a Bihormonal Bionic Endocrine Pancreas.
A fluorescent responsive hybrid nanogel for closed-loop control of glucose.
Pharmacokinetics and Postprandial Glycemic Excursions following Insulin Lispro Delivered by Intradermal Microneedle or Subcutaneous Infusion.
Islet beta-Cell Mass Preservation and Regeneration in Diabetes Mellitus: Four Factors with Potential Therapeutic Interest. Free full text available in HTML and PDF formats (PDF link in HTML page).
Increasing local blood flow by warming the application site: beneficial effects on postprandial glycemic excursions.
Insulin Degludec/Insulin Aspart Administered Once Daily at Any Meal, With Insulin Aspart at Other Meals Versus a Standard Basal-Bolus Regimen in Patients With Type 1 Diabetes.
Relationship between diabetic retinopathy, microalbuminuria and overt nephropathy, and twenty-year incidence follow-up of a sample of type 1 diabetic patients.
Complications of continuous intraperitoneal insulin infusion with an implantable pump. Free full text available in HTML and PDF formats.

August 22, 2012

Proof-of-Concept, Randomized, Controlled Clinical Trial of Bacillus-Calmette-Guerin for Treatment of Long-Term Type 1 Diabetes. Free full text available in HTML format with link to PDF.
Human embryonic stem cell differentiation into insulin secreting beta cells for diabetes. Free full text available in PDF format.
Three-Dimensional Scaffolds Reduce Islet Amyloid Formation and Enhance Survival and Function of Cultured Human Islets.
The Non-Obese Diabetic (NOD) Mouse as a Model of Human Type 1 Diabetes.
The BB Rat as a Model of Human Type 1 Diabetes.

August 8, 2012

Feasibility Study of Automated Overnight Closed-Loop Glucose Control Under MD-Logic Artificial Pancreas in Patients with Type 1 Diabetes: The DREAM Project.
The Use of an Automated, Portable, Glucose Control System for Overnight Glucose Control in Adolescents and Young Adults With Type 1 Diabetes.
Vildagliptin Reduces Glucagon during Hyperglycemia and Sustains Glucagon Counterregulation during Hypoglycemia in Type 1 Diabetes.
Systemic exposure to Pseudomonal bacteria: a potential link between type 1 diabetes and chronic inflammation.
Patient Perspectives on Personalized Glucose Advisory Systems for Type 1 Diabetes Management.
Immunotherapy for Type 1 diabetes: getting beyond a negative first impression.

August 1, 2012

Improvements in the life expectancy of type 1 diabetes; The Pittsburgh Epidemiology of Diabetes Complications Study cohort.
Breast-Feeding and Childhood-Onset Type 1 Diabetes; A pooled analysis of individual participant data from 43 observational studies.
The Effect of Direct Renin Inhibition Alone and in Combination With ACE Inhibition on Endothelial Function, Arterial Stiffness, and Renal Function in Type 1 Diabetes.
History of Cesarean Section Associated with Childhood Onset of T1DM in Newfoundland and Labrador, Canada. Free full text available in HTML and PDF formats.
In vitro generation of functional insulin-producing cells from human bone marrow-derived stem cells, but long-term culture running risk of malignant transformation. Free full text available in HTML and PDF formats.

July 25, 2012

Autologous cord blood harvesting in North Eastern Italy: ethical questions and emerging hopes for curing diabetes and celiac disease. Free full text available in HTML and PDF formats.
Evaluation of a portable ambulatory prototype for automated overnight closed-loop insulin delivery in young people with type 1 diabetes.
Effect of Pramlintide on Prandial Glycemic Excursions During Closed-Loop Control in Adolescents and Young Adults With Type 1 Diabetes.
Potential role of non-insulin adjunct therapy in Type 1 diabetes.
Prevention of type 1 diabetes through infection with an intestinal nematode parasite requires IL-10 in the absence of a Th2-type response.
Detection of hypoglycemia associated EEG changes during sleep in type 1 diabetes mellitus.
Plasma C-peptide concentration in women with Type 1 diabetes during early and late pregnancy.
Bayesian analysis of the geographical variation of type 1 diabetes mellitus in under 15 yr olds in northeast Spain, 1991-2009.
The potential of Fas ligand (apoptosis-inducing molecule) as an unconventional therapeutic target in type 1 diabetes. Free full text available in HTML and PDF formats.

July 18, 2012

Immunoisolation Effect of Polyvinyl Alcohol (PVA) Macroencapsulated Islets in Type 1 Diabetes Therapy.
Relationship between Retinopathy Severity, Visual Impairment and Depression in Persons with Long-term Type 1 Diabetes.

July 4, 2012

Adoptive Transfer of Immunomodulatory M2 Macrophages Prevents Type 1 Diabetes in NOD Mice. See also Researchers prevent mice from developing diabetes.
Long-Term Remission of Diabetes in NOD Mice Is Induced by Nondepleting Anti-CD4 and Anti-CD8 Antibodies.

June 27, 2012

Remission without insulin therapy on gluten-free diet in a 6-year old boy with type 1 diabetes mellitus.
Administration of CD4+CD25highCD127– Regulatory T Cells Preserves beta-Cell Function in Type 1 Diabetes in Children.
Maturation of Human Embryonic Stem Cell�Derived Pancreatic Progenitors into Functional Islets Capable of Treating Pre-existing Diabetes in Mice.

« Previous
1
…
53
54
55
56
57
…
94
Next »

advertisement

Last Updated: Monday, June 16, 2025 18:11:26 UTC

This internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

Terms of Use

About Us

Contact Us
- Contact Us
- Submit a Question

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes, EIN #46-3704802), a 501c3 not-for-profit organization, which is responsible for its contents. By using this site, you agree to our Terms of Use, Legal Notice and Privacy Policy.

Children with Diabetes.com © 1995-2025 | Comments and Feedback | All Rights Reserved.

Social

Four-Star Rating Badge - Full Color

DK Popup

This is a popup.

Submit Your Story

If you’d like your story to be considered for inclusion on our website, please fill out the form below.

Name*
First Last
Email*
Enter Email Confirm Email
Address
State / Province / Region Country

Please let us know about where you live.
Date of Birth*
Month
Day
Year
We ask for your birth date so that we can limit what is used on the website if you are under 18.
Date Diagnosed
Month
Day
Year
If you don't know the exact day, don't worry. Just choose the correct month and/or correct year and note this in your story.
Your Story*
Please tell us about yourself and your connection to diabetes.
Your Photo
Accepted file types: jpg, jpeg, png, Max. file size: 25 MB.
If you have a photo, upload it here.
Short Bio
Please include a short bio of yourself so we can consider it for inclusion with the story. This will appear underneath your photo.
Consent to Use My Story and Photo*
I agree with terms below.
By submitting my information, photo, and/or video, I give Children with Diabetes permission to use my story, imagery, photograph(s), and/or video(s), in its promotional materials and publicity efforts. I understand that the imagery may be used in, but not limited to, a publication, print ad, direct-mail piece, electronic media, or other form or promotion; and that my name and additional information collected by the organization may be used in conjunction with the image(s). I release Children with Diabetes from liability for any violation of any personal or proprietary right I may have in connection with such use.

Contact Us

Help Us Understand You Better.

Please answer a few questions to help us understand how best to serve you. You are not required to answer, but we hope you will. This information will be collated and may be published on our website periodically, or may be used for publication, but we will use composite data only. We do not maintain any individual data from these items. If you ask another question at a later time, please fill this out each time.

This form is just for questions related to diabetes care. If you have questions about anything else related to Children with Diabetes, please use our Contact Us form.
This question is on behalf of:
The question applies to this age group:
This question relates to:
We've had diabetes for:
We use this treatment for diabetes:
We have the following insurance:
We receive diabetes care from:
I'm asking this question because:
Type in Your Question Here.
What is your email address?
If you would like to have the answer emailed to you, please include your email address.
Where do you live?
Please tell us where you live (city, state, and country). This information can help us answer your question.
What is your question?*
To preserve confidentiality, we strongly recommend that you do not include in your question any information that identifies you, your child, or any other individual. Please note: questions that are published may be edited for space and clarity.
Email
This field is for validation purposes and should be left unchanged.

First Name*
Last Name*
Email*
What is your connection to type 1 diabetes?*
- I have type 1 diabetes
- I have a child with type 1 diabetes
- I have type 1 and have a child with type 1
- I am a health care professional
- Other
Name
This field is for validation purposes and should be left unchanged.